Ravi Parthasarathy, a seasoned medical device industry professional with years of experience in product development team leadership, has joined Diality Inc. as Chief Technology Officer. Most recently, he served as Vice President of Device Engineering at ICU Medical. Prior to that, he held leadership roles at Baxter Healthcare, Motorola, Siemens Medical Systems, and General Motors.
Diality’s CEO, Osman Khawar, M.D., expressed his excitement about the addition of Parthasarathy to the team. He noted that Parthasarathy’s experience in developing innovative products and his alignment with Diality’s mission and values made him an ideal fit for the role. Additionally, Clayton Poppe will take on the role of Chief Scientific Officer (CSO) to lead the company’s research, quality, and regulatory functions.
The Moda-flxTM Hemodialysis System is a project that Diality is working on to provide healthcare professionals with the tools they need to make patient-centered decisions and improve clinical practice. Parthasarathy shared his enthusiasm for contributing to this system’s development and highlighted the importance of innovation in improving the quality of life and care for dialysis patients.
Based in Irvine, California, Diality is focused on developing the Moda-flxTM Hemodialysis System. It is important to note that the system is not currently approved for sale in any region. For more information about Diality or its products, visit www.diality.com or find Diality on LinkedIn. For media inquiries, please contact Sam Choinski at Pazanga Health Communications at schoinski@pazangahealth.com or (860) 301-5058
